FSD Pharma Inc Precio/Valor contable
¿Qué es el Precio/Valor contable de FSD Pharma Inc?
El Precio/Valor contable de FSD Pharma Inc es 0.03
¿Cuál es la definición de Precio/Valor contable?
El ratio precio-valor contable representa la relación entre el valor de las acciones de una empresa y el valor contable por acción.
The price to book ratio, or P/B ratio, is a financial ratio used to compare a company's current market price to its book value. It is also sometimes known as a market to book ratio or price to equity ratio. The calculation of a price to book ratio can be performed in two ways. It can be calculated as the company's market capitalization divided by the company's total book value from its balance sheet. It can also be calculated using per-share values and dividing a company's current share price by the book value per share (i.e. its book value divided by the number of outstanding shares).
The P/B ratio varies between industries. The industries that require more infrastructure capital (for each dollar of profit) will usually trade at P/B ratios much lower than, for example, consulting firms. P/B ratios are commonly used to compare banks, because most assets and liabilities of banks are constantly valued at market values. A higher P/B ratio implies that investors expect management to create more value from a given set of assets, all else equal (and/or that the market value of the firm's assets is significantly higher than their accounting value).
P/B ratios do not, however, directly provide any information on the ability of the firm to generate profits or cash for shareholders. This ratio also gives some idea of whether an investor is paying too much for what would be left if the company went bankrupt immediately. For companies in distress, the book value is usually calculated without the intangible assets that would have no resale value. In such cases, P/B should also be calculated on a "diluted" basis, because stock options may well vest on sale of the company or change of control or firing of management.
Precio/Valor contable de compañías en Sector Technology en NASDAQ en comparadas con FSD Pharma Inc
¿Qué hace FSD Pharma Inc?
fsd pharma inc., through its subsidiary, fv pharma inc., produces medical cannabis in canada. the company focuses on the development of indoor grown pharmaceutical grade cannabis; and research and development of various cannabinoid-based treatments for central nervous system disorders and autoimmune diseases of the skin, gi tract, and musculoskeletal system, such as chronic pain. fsd pharma inc. has strategic alliance agreements with scicann therapeutics inc., canntab therapeutics, and solarvest bioenergy inc. the company was founded in 1998 and is headquartered in toronto, canada.
Empresas con precio/valor contable similar a FSD Pharma Inc
- RM2 International S.A tiene Precio/Valor contable de 0.03
- Cypress Environmental Partners L.P tiene Precio/Valor contable de 0.03
- Ethernity Networks tiene Precio/Valor contable de 0.03
- Master Glory tiene Precio/Valor contable de 0.03
- Tencent tiene Precio/Valor contable de 0.03
- Seacoast Commerce Banc tiene Precio/Valor contable de 0.03
- FSD Pharma Inc tiene Precio/Valor contable de 0.03
- Leju Ltd tiene Precio/Valor contable de 0.03
- Datagroup Se tiene Precio/Valor contable de 0.03
- Celanese tiene Precio/Valor contable de 0.03
- Tubesolar Ag Inh O.N tiene Precio/Valor contable de 0.04
- e Athena tiene Precio/Valor contable de 0.04
- Sibanye Stillwater tiene Precio/Valor contable de 0.04